targeting for xklp2 Search Results


targeting protein for xklp2 tpx2 antibodies  (Proteintech)
93
Proteintech targeting protein for xklp2 tpx2 antibodies
Figure 4. Effect of BSAPPT on apoptosis and cycle‑related gene or protein expression in MCF‑7, MCF7/TAMR and other cancer cells. (A) mRNA expres‑ sion levels of genes linked to the cell cycle and apoptosis were measured by qPCR both before and after MCF‑7 and MCF7/TAMR cells were treated with 10 µg/ml BSAPPT. (B) Western blotting detection of apoptotic and cycle‑related protein expression variations in MCF‑7 and MCF7/TAMR cells before and after using 10 µg/ml BSAPPT. Results of qPCR analysis that assessed differences in the level of expression of genes linked to the cell cycle and apoptosis before and after (C) A549 and (D) MDA‑MB‑231 cells were treated with 10 µg/ml BSAPPT. *P<0.05; **P<0.01; ***P<0.001. BSAPPT, bromosulfonamidine amino‑podophyllotoxin; qPCR, quantitative PCR; Bcl‑2, B‑cell lymphoma 2; Caspase, cysteine aspartic acid‑specific protease; PLK, polo like kinase; CCNB1, cyclin B1; <t>TPX2,</t> targeting protein for <t>Xklp2;</t> Bax, Bcl‑2 associated X; Cyt‑C, cytochrome c; Apaf‑1, apoptotic protease activating factor 1.
Targeting Protein For Xklp2 Tpx2 Antibodies, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/targeting+for+xklp2/TPX2+Antibody/pm38910903-73-51-64
Average 93 stars, based on 1 article reviews
targeting protein for xklp2 tpx2 antibodies - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier
anti tpx2  (Boster Bio)
90
Boster Bio anti tpx2
Figure 4. Effect of BSAPPT on apoptosis and cycle‑related gene or protein expression in MCF‑7, MCF7/TAMR and other cancer cells. (A) mRNA expres‑ sion levels of genes linked to the cell cycle and apoptosis were measured by qPCR both before and after MCF‑7 and MCF7/TAMR cells were treated with 10 µg/ml BSAPPT. (B) Western blotting detection of apoptotic and cycle‑related protein expression variations in MCF‑7 and MCF7/TAMR cells before and after using 10 µg/ml BSAPPT. Results of qPCR analysis that assessed differences in the level of expression of genes linked to the cell cycle and apoptosis before and after (C) A549 and (D) MDA‑MB‑231 cells were treated with 10 µg/ml BSAPPT. *P<0.05; **P<0.01; ***P<0.001. BSAPPT, bromosulfonamidine amino‑podophyllotoxin; qPCR, quantitative PCR; Bcl‑2, B‑cell lymphoma 2; Caspase, cysteine aspartic acid‑specific protease; PLK, polo like kinase; CCNB1, cyclin B1; <t>TPX2,</t> targeting protein for <t>Xklp2;</t> Bax, Bcl‑2 associated X; Cyt‑C, cytochrome c; Apaf‑1, apoptotic protease activating factor 1.
Anti Tpx2, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/targeting+for+xklp2/Anti-TPX2+Antibody/pmc07409503-80-29-33
Average 90 stars, based on 1 article reviews
anti tpx2 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
targeting for xklp2  (InterPro Inc)
90
InterPro Inc targeting for xklp2
Figure 4. Effect of BSAPPT on apoptosis and cycle‑related gene or protein expression in MCF‑7, MCF7/TAMR and other cancer cells. (A) mRNA expres‑ sion levels of genes linked to the cell cycle and apoptosis were measured by qPCR both before and after MCF‑7 and MCF7/TAMR cells were treated with 10 µg/ml BSAPPT. (B) Western blotting detection of apoptotic and cycle‑related protein expression variations in MCF‑7 and MCF7/TAMR cells before and after using 10 µg/ml BSAPPT. Results of qPCR analysis that assessed differences in the level of expression of genes linked to the cell cycle and apoptosis before and after (C) A549 and (D) MDA‑MB‑231 cells were treated with 10 µg/ml BSAPPT. *P<0.05; **P<0.01; ***P<0.001. BSAPPT, bromosulfonamidine amino‑podophyllotoxin; qPCR, quantitative PCR; Bcl‑2, B‑cell lymphoma 2; Caspase, cysteine aspartic acid‑specific protease; PLK, polo like kinase; CCNB1, cyclin B1; <t>TPX2,</t> targeting protein for <t>Xklp2;</t> Bax, Bcl‑2 associated X; Cyt‑C, cytochrome c; Apaf‑1, apoptotic protease activating factor 1.
Targeting For Xklp2, supplied by InterPro Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/targeting+for+xklp2/targeting+for+xklp2/pmc03557298__pone__0054762__s005-56-67-68
Average 90 stars, based on 1 article reviews
targeting for xklp2 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Figure 4. Effect of BSAPPT on apoptosis and cycle‑related gene or protein expression in MCF‑7, MCF7/TAMR and other cancer cells. (A) mRNA expres‑ sion levels of genes linked to the cell cycle and apoptosis were measured by qPCR both before and after MCF‑7 and MCF7/TAMR cells were treated with 10 µg/ml BSAPPT. (B) Western blotting detection of apoptotic and cycle‑related protein expression variations in MCF‑7 and MCF7/TAMR cells before and after using 10 µg/ml BSAPPT. Results of qPCR analysis that assessed differences in the level of expression of genes linked to the cell cycle and apoptosis before and after (C) A549 and (D) MDA‑MB‑231 cells were treated with 10 µg/ml BSAPPT. *P<0.05; **P<0.01; ***P<0.001. BSAPPT, bromosulfonamidine amino‑podophyllotoxin; qPCR, quantitative PCR; Bcl‑2, B‑cell lymphoma 2; Caspase, cysteine aspartic acid‑specific protease; PLK, polo like kinase; CCNB1, cyclin B1; TPX2, targeting protein for Xklp2; Bax, Bcl‑2 associated X; Cyt‑C, cytochrome c; Apaf‑1, apoptotic protease activating factor 1.

Journal: Oncology letters

Article Title: Reversal of the tamoxifen‑resistant breast cancer malignant phenotype by proliferation inhibition with bromosulfonamidine amino‑podophyllotoxin.

doi: 10.3892/ol.2024.14506

Figure Lengend Snippet: Figure 4. Effect of BSAPPT on apoptosis and cycle‑related gene or protein expression in MCF‑7, MCF7/TAMR and other cancer cells. (A) mRNA expres‑ sion levels of genes linked to the cell cycle and apoptosis were measured by qPCR both before and after MCF‑7 and MCF7/TAMR cells were treated with 10 µg/ml BSAPPT. (B) Western blotting detection of apoptotic and cycle‑related protein expression variations in MCF‑7 and MCF7/TAMR cells before and after using 10 µg/ml BSAPPT. Results of qPCR analysis that assessed differences in the level of expression of genes linked to the cell cycle and apoptosis before and after (C) A549 and (D) MDA‑MB‑231 cells were treated with 10 µg/ml BSAPPT. *P<0.05; **P<0.01; ***P<0.001. BSAPPT, bromosulfonamidine amino‑podophyllotoxin; qPCR, quantitative PCR; Bcl‑2, B‑cell lymphoma 2; Caspase, cysteine aspartic acid‑specific protease; PLK, polo like kinase; CCNB1, cyclin B1; TPX2, targeting protein for Xklp2; Bax, Bcl‑2 associated X; Cyt‑C, cytochrome c; Apaf‑1, apoptotic protease activating factor 1.

Article Snippet: Mouse anti‐human Caspase‐9 antibodies (cat. no. 9508S; 1:1,000) were purchased from Cell Signaling Technology, Inc., rabbit anti‐human Bcl‐2 (cat. no. BA0412; 1:1,000) and cyclin B1 (CCNB1; cat. no. BA0766; 1:1,000) antibodies were purchased from Wuhan Boster Biological Technology, Ltd., rabbit anti‐human polo like kinase (PLK)‐1 antibodies (cat. no. 10305‐1‐AP; 1:1,000) and targeting protein for Xklp2 (TPX2) antibodies (cat. no. 11741‐1‐AP; 1:2,000) were purchased from Proteintech Group, Inc., and the rabbit anti‐human PLK‐4 antibodies (cat. no. A9863; 1:1,000) were purchased from ABclonal Biotech Co., Ltd.

Techniques: Expressing, Western Blot, Real-time Polymerase Chain Reaction